Colby Pharmaceutical Company

Loading menu...

Prostate Cancer (PCa) will affect most men if they live long enough and PCa is one of the leading causes of cancer deaths.

Each year over 200,000 men are newly diagnosed with PCa in North America.

CPC-100 is for asympto-matic 'watchfull waiting' PCa patients who fail prostate removal & hormone therapy, with no approved drug availble to them.

Drugs for therapy-resitant solid cancers & hypoxic conditions

Colby's mission is to develop & sell drugs for hypoxia & therapy-resistant tumors

Colby drugs resore therapy-sensitivity or normoxia

Colby Pharmaceutical Company has operations in Menlo Park, California and Madison, Wisconsin.

Colby Headquarters

1095 Colby Avenue, Suite C
Menlo Park, California, 94025-2334

Telephone: (650) 333-3150
Fax: (650) 323-6215

Colby Clinical Drug Development Office

7226 Colony Drive, Suite 04
Madison, Wisconsin, 53717-1412

Telephone: (608) 358-5074
Fax: (650) 323-6215
E-mail: info@colbypharmaceuticals.com